NFKB1 and diabetes mellitus: (SE) could inhibit AGEs–RAGE interactions and subsequent NF-κB activation of RAGE downstream signaling, LPS-induced RAGE-dependent inflammatory reactions, and vascular endothelial dysfunction in diabetes.